| Bioactivity | Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer[1][2]. |
| Invitro | Myosin light chain kinase fragment 11-19 amide (5 μM) reduces the amplitude and rate of activation of noradrenaline-evoked non-selective cation current (Icat) in rabbit portal vein myocytes[1].Myosin light chain kinase fragment 11-19 amide inhibits swelling-activated taurine transport with an IC50 value of 2.0 µM[2].Myosin light chain kinase fragment 11-19 amide (10 µM) inhibits β2-integrin-mediated adhesion in neutrophils treated with KT5720 (25 µM)[3]. |
| Name | Myosin light chain kinase fragment 11-19 amide |
| CAS | 119386-39-9 |
| Shortening | KKRAARATS-NH2 |
| Formula | C40H78N18O11 |
| Molar Mass | 987.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Myosin light chain kinase fragment 11-19 amide
CAS: 119386-39-9 F: C40H78N18O11 W: 987.16
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. My
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.